Adamis files definitive proxy statement and sends letter to stockholders

San diego--(business wire)--adamis pharmaceuticals corporation (nasdaq: admp) today announced that it has filed its definitive proxy statement with the u.s. securities and exchange commission and sent the below letter to stockholders. the letter has been signed by all five members of the company's board of directors: howard c. birndorf, roshawn blunt, dennis j. carlo, ph.d., david j. marguglio and richard c. williams. *** june 14, 2021 dear stockholder, the board of directors (the "board") than
ADMP Ratings Summary
ADMP Quant Ranking